Ann: TOV: Panel Receives Application, page-22

The placebo group performed to well for a bad illness with an always advertised no valuable cure.

This results has been fishy and the outcome has been a killing.
I repeat that this product was not an hard to analyze ingested pill, but a progress visible topical product.

If $70 million spent was not good enough to assess a easy visible topical product, all the management has to be kicked out in the ass.

There is no justification for this failure. All was supposed to be a de-risked Investment.

It is a fact that in the years the directors and the consultants made out a living from our hard earned money.